A new nasal vaccine against influenza, which helps patients avoid the needle, has caused no unexpected side-effects, U.S. government researchers reported Tuesday.
A study of the 2.5 million people who got the vaccine over the past two flu seasons showed no unexpected serious risks, according to the report in the Journal of the American Medical Association.
FluMist has been approved since 2003 for use against the seasonal flu, which kills 36,000 Americans every year and as many as 500,000 globally in an average flu season. But people have been slow to use it, despite efforts by U.S. health officials to promote its use
This is a great alternative for healthy, younger patients, especially those that are adverse to needles, such as children over 8 years old. It can set off asthmatic episodes in the series in a small percentage of patients with known asthma.
No comments:
Post a Comment